213886-98-7

Basic information

• Product Name: 1-acetyl-N-methoxy-N-methylpiperidine-4-carboxamide
• Synonyms: 1-acetyl-N-methoxy-N-methylpiperidine-4-carboxamide
• CAS NO: 213886-98-7
• Molecular Weight: 214.265
• Mol File: 213886-98-7.mol
• Article Data: 6

Chemical Properties

• CAS DataBase Reference: 1-acetyl-N-methoxy-N-methylpiperidine-4-carboxamide(CAS DataBase Reference)
• NIST Chemistry Reference: 1-acetyl-N-methoxy-N-methylpiperidine-4-carboxamide(213886-98-7)
• EPA Substance Registry System: 1-acetyl-N-methoxy-N-methylpiperidine-4-carboxamide(213886-98-7)

Safety Data

• Hazardous Substances Data: 213886-98-7(Hazardous Substances Data)

Usage

Chemical class

Arylpiperidines

Use

Anesthetic and tranquilizer in veterinary medicine

Combination use

With zolazepam in an intramuscular injection

Effect

Produces dissociative anesthesia

Symptoms

Causes sedation, muscle relaxation, and analgesia in animals

Similarity

Pharmacological effects are similar to ketamine

Mechanism

Acts as an NMDA receptor antagonist

Research

Investigated as a potential treatment for depression and anxiety in humans

Unique properties

Due to its unique pharmacological properties, Tiletamine has potential therapeutic applications beyond veterinary medicine.

Upstream product

• 25503-90-6 1-acetyl-piperidine-4-carboxylic acid 
• 498-94-2 isonipecotic acid 
• 6638-79-5 N,O-dimethylhydroxylamine*hydrochloride 

Downstream Products

• 162368-02-7 1-(1-acetylpiperidin-4-yl)-2-bromoethanone 
• 953044-73-0 1-(4-(2-(5-(3-methylthieno[3,2-b]pyridin-7-ylthio)-3-phenoxypyridin-2-ylamino)thiazol-4-yl)piperidin-1-yl)ethanone 
• 953130-97-7 1-(4-(2-(3-phenoxy-5-(thieno[3,2-b]pyridin-7-ylthio)pyridin-2-ylamino)thiazol-4-yl)piperidin-1-yl)ethanone 
• 953044-77-4 1-(4-(2-(3-phenoxy-5-(thieno[2,3-d]pyrimidin-4-ylthio)pyridin-2-ylamino)thiazol-4-yl)piperidin-1-yl)ethanone 
• 1065604-63-8 1-(4-(2-(5-(3-hydroxypropylthio)-3-phenoxypyridin-2-ylamino)thiazol-4-yl)piperidin-1-yl)ethanone 
• 953046-49-6 methyl 3-(6-(4-(1-acetylpiperidin-4-yl)thiazol-2-ylamino)-5-phenoxypyridin-3-ylthio)propanoate 
• 953131-47-0 1-(4-(2-(3-phenoxy-5-(pyridin-2-ylthio)pyridin-2-ylamino)thiazol-4-yl)piperidin-1-yl)ethanone 
• 953130-88-6 1-(4-(2-(5-bromo-3-phenoxypyridin-2-ylamino)thiazol-4-yl)piperidin-1-yl)ethanone 
• 25519-77-1 1-(4-(4-fluorobenzoyl)piperidin-1-yl)ethanone 
• 149452-44-8 4-(4-trifluoromethylbenzoyl)piperidine 
• 56346-57-7 (4-fluorophenyl)-piperidin-4-ylmethanone 
• 162368-01-6 N-acetyl-1-(piperidin-4-yl)ethanone 

Relevant articles and documents

NOVEL GPR119 AGONIST COMPOUNDS

The present invention relates to novel compounds of formula (I), process for preparation of the same and composition comprising these compounds.

METHYLENE LINKED QUINOLINYL MODULATORS OF ROR-GAMMA-T

The present invention comprises compounds of Formula (I). wherein: R1, R2, R3, R4, R5, R6, R7, R8, and R9 are defined in the specification. The invention also comprises a method of treating or ameliorating a syndrome, disorder or disease, wherein said syndrome, disorder or disease is rheumatoid arthritis or psoriasis. The invention also comprises a method of modulating RORγt activity in a mammal by administration of a therapeutically effective amount of at least one compound of claim 1.

2-AMINOPYRIDINE ANALOGS AS GLUCOKINASE ACTIVATORS

Provided are compounds that are useful in the treatment and/or prevention of diseases mediated by deficient levels of glucokinase activity, such as diabetes mellitus. Also provided are methods of treating or preventing diseases and disorders characterized by underactivity of glucokinase or which can be treated by activating glucokinase.